We are live on ! Find out more
MAIA icon

MAIA Biotechnology
MAIA

22 hedge funds and large institutions have $964K invested in MAIA Biotechnology in 2023 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

900% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 1

800% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 1

57% more funds holding

Funds holding: 14 → 22 (+8)

38% more capital invested

Capital invested by funds: $700K → $964K (+$264K)

2.45% more ownership

Funds ownership: 2.33% → 4.77% (+2.4%)

Holders
22
Holders Change
+8
Holders Change %
+57.14%
% of All Funds
0.32%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
10
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$211K
2
Renaissance Technologies
Renaissance Technologies
New York
+$179K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$130K
4
Citadel Advisors
Citadel Advisors
Florida
+$92.8K
5
BCM
Bridgeway Capital Management
Texas
+$38.9K

Top Sellers

Rank Fund Capital Flow
1
FIA
FNY Investment Advisers
New York
-$38K
2
TRCT
Tower Research Capital (TRC)
New York
-$2.15K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$204K +$130K +80,659 +86%
SM
2
Sabby Management
Florida
$153K +$211K +130,510 New
Renaissance Technologies
3
Renaissance Technologies
New York
$130K +$179K +111,200 New
CWM
4
Centric Wealth Management
Illinois
$96.8K +$4.1K +2,542 +4%
BCM
5
Bridgeway Capital Management
Texas
$88.6K +$38.9K +24,100 +47%
Citadel Advisors
6
Citadel Advisors
Florida
$67.2K +$92.8K +57,473 New
Geode Capital Management
7
Geode Capital Management
Massachusetts
$52.2K – – –
XT
8
XTX Topco
Cayman Islands
$28K +$38.7K +23,965 New
NW
9
Naviter Wealth
Arkansas
$25.9K – – –
State Street
10
State Street
Massachusetts
$24.9K +$34.4K +21,300 New
Northern Trust
11
Northern Trust
Illinois
$23.7K +$32.7K +20,273 New
BlackRock
12
BlackRock
New York
$20.1K +$5.22K +3,237 +23%
Wealth Enhancement Advisory Services
13
Wealth Enhancement Advisory Services
Minnesota
$17.3K +$23.9K +14,800 New
BCM
14
Brookstone Capital Management
Illinois
$14.8K +$20.4K +12,658 New
Morgan Stanley
15
Morgan Stanley
New York
$11.9K +$8.22K +5,095 +100%
TRCT
16
Tower Research Capital (TRC)
New York
$4.21K -$2.15K -1,329 -27%
UBS Group
17
UBS Group
Switzerland
$1.17K +$1.4K +865 +650%
SS
18
Sunbelt Securities
Texas
$176 +$161 +100 +200%
JP Morgan Chase
19
JP Morgan Chase
New York
$91 +$108 +67 +609%
Wells Fargo
20
Wells Fargo
California
$81 +$10 +6 +10%
Bank of America
21
Bank of America
North Carolina
$9 +$13 +8 New
FIA
22
FNY Investment Advisers
New York
– -$38K -17,550 Closed
Royal Bank of Canada
23
Royal Bank of Canada
Ontario, Canada
– +$195 +121 +448%

MAIA Hedge Fund Activity: Q4 2023 in Review

22 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in MAIA Biotechnology (MAIA) for Q4 2023, worth a combined $964K — up 38% from $700K a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new MAIA positions and 1 closed out — a net gain of 8 holders — while 10 added to existing stakes and 1 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $211K. The largest seller was FNY Investment Advisers, exiting entirely with an estimated $38K sold.

  • 22 institutional investors held MAIA Biotechnology (MAIA) as of Q4 2023, up from 14 in Q3 2023.
  • Funds reported $964K of MAIA Biotechnology stock for Q4 2023, up 38% quarter-over-quarter.
  • 9 funds opened new MAIA Biotechnology positions in Q4 2023 and 1 closed out, a net change of +8 holders.
  • The largest MAIA Biotechnology buyer in Q4 2023 was Sabby Management, an estimated $211K added.
  • The largest MAIA Biotechnology seller in Q4 2023 was FNY Investment Advisers, an estimated $38K sold.

Based on aggregated 13F filings for Q4 2023.